中华生物医学工程杂志
中華生物醫學工程雜誌
중화생물의학공정잡지
CHINESE JOURNAL OF BIOMEDICAL ENGINEERING
2010年
5期
476-479
,共4页
谭红鹰%林文前%操隆辉%钟忠健%曾维安
譚紅鷹%林文前%操隆輝%鐘忠健%曾維安
담홍응%림문전%조륭휘%종충건%증유안
插管法,气管内%支气管镜检查%二异丙酚%瑞芬太尼%麻醉
插管法,氣管內%支氣管鏡檢查%二異丙酚%瑞芬太尼%痳醉
삽관법,기관내%지기관경검사%이이병분%서분태니%마취
Intubation,intratracheal%Bronchoscopy%Propofol%Remifentanil%Anesthesia
目的 评价丙泊酚联合瑞芬太尼靶控输注(TCI)麻醉诱导,用于纤维支气管镜(FOB)气管插管的可行性,并与手控输注(MCI)相比较.方法 2009年12月到2010年1月本院24例预计无困难气道,择期气管插管全身麻醉手术患者,完全随机分为TCI组及MCI组(每组12例).分别以TCI或MCI丙泊酚联合瑞芬太尼诱导下行FOB插管.记录诱导期间血压、心率、脉搏氧饱和度,Narcotrend指数(N1)监测麻醉深度,记录意识消失时间、插管时间、插管评分、用药量及不良反应.结果 TCI组患者意识消失时间、插管时间比MCI组显著缩短[(2.2±0.5)比(5.3±2.3)min,(7.7±3.9)比(12.5±4.5)min,P<0.01].2组插管评分、丙泊酚及瑞芬太尼用量差异无统计学意义.2组血压、心率诱导后均较诱导前明显下降,插管后MCI组心率明显低于TCI组(P<0.05).TCI组NI值下降较MCI组快速.2组未见明显不良反应,对插管过程无记忆.结论 丙泊酚联合瑞芬太尼诱导可安全有效用于无全身麻醉诱导禁忌患者FOB气管插管.其中TCI模式较MCI模式,诱导及插管迅速,血流动力学更平稳.
目的 評價丙泊酚聯閤瑞芬太尼靶控輸註(TCI)痳醉誘導,用于纖維支氣管鏡(FOB)氣管插管的可行性,併與手控輸註(MCI)相比較.方法 2009年12月到2010年1月本院24例預計無睏難氣道,擇期氣管插管全身痳醉手術患者,完全隨機分為TCI組及MCI組(每組12例).分彆以TCI或MCI丙泊酚聯閤瑞芬太尼誘導下行FOB插管.記錄誘導期間血壓、心率、脈搏氧飽和度,Narcotrend指數(N1)鑑測痳醉深度,記錄意識消失時間、插管時間、插管評分、用藥量及不良反應.結果 TCI組患者意識消失時間、插管時間比MCI組顯著縮短[(2.2±0.5)比(5.3±2.3)min,(7.7±3.9)比(12.5±4.5)min,P<0.01].2組插管評分、丙泊酚及瑞芬太尼用量差異無統計學意義.2組血壓、心率誘導後均較誘導前明顯下降,插管後MCI組心率明顯低于TCI組(P<0.05).TCI組NI值下降較MCI組快速.2組未見明顯不良反應,對插管過程無記憶.結論 丙泊酚聯閤瑞芬太尼誘導可安全有效用于無全身痳醉誘導禁忌患者FOB氣管插管.其中TCI模式較MCI模式,誘導及插管迅速,血流動力學更平穩.
목적 평개병박분연합서분태니파공수주(TCI)마취유도,용우섬유지기관경(FOB)기관삽관적가행성,병여수공수주(MCI)상비교.방법 2009년12월도2010년1월본원24례예계무곤난기도,택기기관삽관전신마취수술환자,완전수궤분위TCI조급MCI조(매조12례).분별이TCI혹MCI병박분연합서분태니유도하행FOB삽관.기록유도기간혈압、심솔、맥박양포화도,Narcotrend지수(N1)감측마취심도,기록의식소실시간、삽관시간、삽관평분、용약량급불량반응.결과 TCI조환자의식소실시간、삽관시간비MCI조현저축단[(2.2±0.5)비(5.3±2.3)min,(7.7±3.9)비(12.5±4.5)min,P<0.01].2조삽관평분、병박분급서분태니용량차이무통계학의의.2조혈압、심솔유도후균교유도전명현하강,삽관후MCI조심솔명현저우TCI조(P<0.05).TCI조NI치하강교MCI조쾌속.2조미견명현불량반응,대삽관과정무기억.결론 병박분연합서분태니유도가안전유효용우무전신마취유도금기환자FOB기관삽관.기중TCI모식교MCI모식,유도급삽관신속,혈류동역학경평은.
Objective To evaluate the feasibility of combined Propofol and Remifentanil targetcontrolled infusion (TCI) for anesthesia induction during tracheal intubation under fibreoptic bronchoscope (FOB) , and to compare the outcomes with manually controlled infusion (MCI). Methods Between December 2009 and January 2010, 24 patients registered to our hospital, who were predictedly without difficult airway and scheduled for elective surgery under general anesthesia with tracheal intubation, were randomly divided into two groups: TCI group and MCI group (n=12 each). FOB intubation was completed under TCI or MCI Propofol and Remifentanil induction respectively. Blood pressure(BP), heart rate(HR),SPO2, and Narcotrend index (NI)were used to monitor anesthetic depth during the induction. In addition,time to loss of eonciousness (LOC), intubation time, intubation score, anesthetic dosage and adverse effects were recorded. Results LOC and intubation time of TCI group were significantly shorter than those of MCI group [ (2.2±0.5) vs (5.3±2.3)min and (7.7±3.9) vs (12.5±4.5)min, respectively,P<0.01 ]. No significant differences in intubation score, Propofol and Remifentanil dosage were found between the two groups. BP and HR decreased significantly after induction in both groups (P<0.05), with MCI group showing greater decrease in HR after intubation compared to TCI group(P<0.05). NI of TCI group dropped faster than that of MCI group (P<0.05) . Neither significant adverse effects nor recall about intubation was noted.Conclusions Propofol and Remifentanil induction can be safe and effective for FOB intubation in the patients without general anesthesia contraindications. Compared with MCI mode, TCI mode can provide faster induction and intubation with more stable haemodynamics.